GJA1 and myeloid sarcoma: Therefore, loss of astroglial Cx43 may exacerbate demyelinating disease by A/O GJ disruption leading to distal oligodendrogliopathy, and through dysregulation of BBB function, which may explain the rapidly progressive course and higher frequency of relapses in MS and NMO patients with Cx43 loss.